Clinical Trial Update: Evaluation of Response to Biosimilar Erythropoietin Alfa Therapy in Anemic Patients With Myelodysplastic Syndrome

View source ↗

Summary

A clinical trial is evaluating the response to a biosimilar erythropoietin alfa therapy in anemic patients with myelodysplastic syndromes and is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Biosimilar erythropoietin alfa (erythropoietin alfa biosimilar)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Myelodysplastic Syndromes (MDS) | Status: RECRUITING